Continous Treatment with Ibrutinib in 100 Untreated Patients with TP53 Disrupted Chronic Lymphocytic Leukemia. A Real‐Life Campus CLL Study

Corresponding Author

Livio Trentin MD

Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padova

Venetian Institute of Molecular Medicine, Padua

Correspondence

Prof. Livio Trentin, M.D. Hematology and Clinical Immunology Unit Department of Medicine University of Padua Via Giustiniani, 2 - 35128 Padova Email: livio.trentin@unipd.it phone: 0039 049 821 2298 fax: 0039 049 821 1970

Search for more papers by this author

留言 (0)

沒有登入
gif